1 Min Read
July 14 (Reuters) - Newron Pharmaceuticals SpA :
* Receives FDA orphan drug designation for Sarizotan for treatment of Rett Syndrome Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.